SCHEMBL6479952

SCHEMBL6479952

O=C(NCc1ccccc1)c1cc(-c2cc3ccccc3[nH]2)[nH]n1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ITK Q08881 3/20 0.57
▸ PIP5K1C O60331 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ MMP13 P45452 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ EGFR P00533 1/20 0.45
▸ CA12 O43570 1/20 0.45
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ PDE2A O00408 1/20 0.45
▸ CNR2 P34972 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5755119 0.78 HSP90AA1 (0.57) ITKPIP5K1CKDM4ESMN1; SMN2
SCHEMBL2735969 0.76 CA12 (0.72) KDM4EALDH1A1CA12CA1CA2
SCHEMBL6415974 0.75 ITK (0.62) ITKPIP5K1C
SCHEMBL29114944 0.75 ALDH1A1 (0.53) KDM4EMMP13ALDH1A1HPGDCYP1A2
SCHEMBL29115001 0.75 CYP1A2 (0.53) MMP13ALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL34468710 0.73 KDM4E (0.64) KDM4EALDH1A1HPGDCA12CA1
SCHEMBL29114965 0.71 DYRK1A (0.51) MMP13CYP2C19SMN1; SMN2
SCHEMBL8211246 0.71 NAMPT (0.51) ALDH1A1HPGDCA1CA2SMN1; SMN2
SCHEMBL6479947 0.71 PIP5K1C (0.49) ITKPIP5K1CCNR2
SCHEMBL15606227 0.70 CNR2 (0.48) MMP13PDE2ACNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2005-02-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K9, MAP3K20, MAP3K19 ITK 392/4885PIP5K1C 70/4885KDM4E 765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback